THANK YOU FOR SUBSCRIBING
FundamentalVR offers Teleflex a scalable training platform to accelerate the effective use of the Urolift 2 system for the treatment of prostate enlargement.
FREMONT, CA: "We are delighted to offer our customers this leading VR platform for surgical and procedural education, which offers advanced, realistic graphics to help demonstrate the ease of use of the UroLift® 2 System in a variety of prostate anatomies," says Kevin Hardage, President and General Manager of Teleflex Interventional Urology. Teleflex Incorporated, a leading global provider of medical technologies, has partnered with FundamentalVR, the global leader in virtual reality (VR) integration for medical simulation. The agreement will provide Teleflex with a virtual reality (VR) training platform to expedite the company's UroLift 2 System, innovative technology for treating benign prostatic hyperplasia (BPH) or enlarged prostate. The VR training platform combines tactile feedback and a digital representation of the UroLift 2 System to provide urologists with a "hands-on" VR experience that can accelerate their learning.
“FundamentalVR’s Fundamental Surgery platform is versatile and scalable, making them an ideal supplier to meet our customers’ needs for training for the UroLift 2 System around the world,” adds Hardage.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
By leveraging FundamentalVR's Fundamental Surgery platform, Teleflex aims to increase the accessibility and standardization of clinical training for the UroLift 2 System in the United States and internationally, including in Japan, where the device was recently approved for use. Global urologists can practice the procedure remotely in a virtual environment thanks to the customized solution developed by FundamentalVR.
At the American Urological Association (AUA) meeting in New Orleans in 2022, Teleflex displayed the Fundamental Surgery platform at its UroLift System booth.
“We are delighted that Teleflex, a market leader in urology, has chosen FundamentalVR as their partner for their future vision. Integrating Extended Reality education solutions can have a positive impact on surgeons and patients,” says Chris Scattergood, co-founder at FundamentalVR.
Teleflex is a global provider of medical technologies aimed at enhancing the health and quality of human life. To benefit patients and healthcare providers, they employ purpose-driven innovation — a tenacious pursuit of identifying unmet clinical needs.
The UroLift System is a minimally invasive treatment for benign prostatic hyperplasia-related lower urinary tract symptoms (BPH). It is indicated for treating symptoms associated with a prostate enlargement of up to 100 cc in men aged 45 or older (50 years outside the U.S.).
FundamentalVR provides multi-user simulations with high-fidelity immersion and HapticVRTM interactions. This enables medical devices and procedures to ensure consistency and compliance throughout their training programs, which are offered on their multimodal Fundamental Surgery platform.
More in News